RAPPORT THERAPEUTICS INC. - COMMON STOCK

16.69

08-一月-25 16:45:00

15 分钟延时

股票

-1.10

-6.16%

今日范围

16.34 - 17.53

ISIN

N/A

来源

NASDAQ

CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

09 1月 2025 09:12:59 条件 Nasdaq GlobeNewswire
Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

09 1月 2025 07:00:00 条件 Nasdaq GlobeNewswire
Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures

06 12月 2024 12:01:00 条件 Nasdaq GlobeNewswire
Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting

14 11月 2024 07:00:02 条件 Nasdaq GlobeNewswire
Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update

07 11月 2024 07:00:01 条件 Nasdaq GlobeNewswire
Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November

04 11月 2024 07:00:00 条件 Nasdaq GlobeNewswire
Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences

05 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire

<<
<
1
>

我同意 NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie 政策, 隐私政策 and 条款与条件.